CHERYL MCDANIEL: Open Payments
NPI 1063191450 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 66 payments from 9 companies in 2025. Trend: 2023 $420 · 2024 $1,576 · 2025 $1,376
Food & beverage: $1,376
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $460 |
| Otsuka America Pharmaceutical, Inc. | 9 | $215 |
| Alkermes, Inc. | 13 | $191 |
| Neurocrine BioSciences, Inc. | 6 | $186 |
| Vanda Pharmaceuticals Inc. | 14 | $177 |
| Janssen Pharmaceuticals, Inc | 3 | $79 |
| ABBVIE INC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: COBENFY, REXULTI, INGREZZA, FANAPT, ARISTADA, LYBALVI, SPRAVATO, VRAYLAR.
Industry payments across GA — which companies pay providers there.
